Business Insider2y
CRISPR pioneer Feng Zhang is building a secretive new startup trying to solve gene editing's biggest problem: getting into more parts of the body
The CRISPR pioneer Feng Zhang is launching yet another ambitious gene-editing startup, backed by approximately $200 million from some of biotech's biggest investors. The Cambridge, Massachusetts ...
pharmaphorum1y
Aera Tx launches with $193m in financing for genetic meds
Boston-based biotech Aera Therapeutics has announced that it has launched with $193 million in financing – raised from Series A and B financings from leading life sciences investors ARCH Venture ...